Georgia Erbez, Chief Financial Officer at Harpoon Therapeutics, Inc. (HARP), bought 7,098 shares at $11.40 ($81K) on 2020-08-19, disclosed to the SEC on 2020-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.60 | 2,098 | $24K | 29.9% |
| 2 | $11.40 | 5,000 | $57K | 70.1% |
| Total | $11.46 avg | 7,098 | $81K | 100% |
| Filing → |
| CDXS | SELL | 2025-10-15 | $16K | — | Filing → |
| HARP | BUY | 2021-09-22 | $83K | — | Filing → |
| HARP | BUY | 2020-08-04 | $20K | — | Filing → |